<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-166506" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Urrets-Zavalia Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moshirfar</surname>
            <given-names>Majid</given-names>
          </name>
          <aff>University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moin</surname>
            <given-names>Kayvon A.</given-names>
          </name>
          <aff>American University of the Caribbean School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ronquillo</surname>
            <given-names>Yasmyne</given-names>
          </name>
          <aff>Hoopes Vision Research Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Majid Moshirfar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kayvon Moin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasmyne Ronquillo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>6</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-166506.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>In 1963, Alberto Urrets-Zavalia, an Argentinian ophthalmologist, observed 6 patients with fixed mydriatic pupil, iris atrophy, posterior synechiae, and secondary glaucoma after undergoing penetrating keratoplasty for keratoconus.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref>&#x000a0;All cases except 1 received topical atropine in this series, and the author suggested that atropine was crucial in causing this clinical condition.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref>&#x000a0;</p>
        <p>Urrets-Zavalia Syndrome (UZS), also known as Castroviejo syndrome, is a rare and severe complication characterized by a fixed and dilated pupil following various ophthalmic surgeries, sometimes associated with keratoconus or the use of postoperative mydriatic agents.<xref ref-type="bibr" rid="article-166506.r2">[2]</xref><xref ref-type="bibr" rid="article-166506.r3">[3]</xref>&#x000a0;Castroviejo was the first to&#x000a0;mention this clinical condition, while Urrets-Zavalia provided a detailed characterization of the condition.<xref ref-type="bibr" rid="article-166506.r2">[2]</xref><xref ref-type="bibr" rid="article-166506.r3">[3]</xref><xref ref-type="bibr" rid="article-166506.r4">[4]</xref></p>
        <p>Although penetrating keratoplasty&#x000a0;is the most common implicated procedure for this syndrome,<xref ref-type="bibr" rid="article-166506.r5">[5]</xref>&#x000a0;UZS has been reported&#x000a0;following various&#x000a0;ophthalmic surgical procedures, including deep anterior lamellar keratoplasty (DALK),<xref ref-type="bibr" rid="article-166506.r6">[6]</xref> Descemet stripping automated endothelial keratoplasty (DSAEK),<xref ref-type="bibr" rid="article-166506.r7">[7]</xref> cataract surgery,<xref ref-type="bibr" rid="article-166506.r8">[8]</xref> and various glaucoma surgeries.<xref ref-type="bibr" rid="article-166506.r9">[9]</xref><xref ref-type="bibr" rid="article-166506.r10">[10]</xref><xref ref-type="bibr" rid="article-166506.r11">[11]</xref>&#x000a0;Patients usually present with an atonic pupil that does not constrict to light or accommodation.<xref ref-type="bibr" rid="article-166506.r12">[12]</xref> The onset of symptoms varies but commonly occurs 1 to 2 weeks after penetrating keratoplasty.<xref ref-type="bibr" rid="article-166506.r13">[13]</xref></p>
        <p>The development of UZS is widely&#x000a0;attributed&#x000a0;to iris ischemia,<xref ref-type="bibr" rid="article-166506.r14">[14]</xref>&#x000a0;which results in subsequent dysfunction of the pupillary sphincter muscles.<xref ref-type="bibr" rid="article-166506.r15">[15]</xref>&#x000a0;Although various preventive measures have been attempted,<xref ref-type="bibr" rid="article-166506.r16">[16]</xref><xref ref-type="bibr" rid="article-166506.r17">[17]</xref>&#x000a0;an approved treatment for UZS is not currently available.&#x000a0;</p>
      </sec>
      <sec id="article-166506.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Although the etiology of UZS is not well understood,&#x000a0;several potential risk factors mentioned below are believed to be involved in its development:</p>
        <list list-type="bullet">
          <list-item>
            <p>Increased intraoperative or postoperative intraocular pressure (IOP)&#x000a0;<xref ref-type="bibr" rid="article-166506.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Use of mydriatic agents during or after surgical intervention&#x000a0;<xref ref-type="bibr" rid="article-166506.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Presence of keratoconus&#x000a0;<xref ref-type="bibr" rid="article-166506.r2">[2]</xref><xref ref-type="bibr" rid="article-166506.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Retention of viscoelastic material in the anterior chamber angle <xref ref-type="bibr" rid="article-166506.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>Air or gas injection into the anterior chamber <xref ref-type="bibr" rid="article-166506.r21">[21]</xref><xref ref-type="bibr" rid="article-166506.r22">[22]</xref><xref ref-type="bibr" rid="article-166506.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Inflammation in the anterior chamber&#x000a0;<xref ref-type="bibr" rid="article-166506.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>These risk factors have been debated due to conflicting data from limited reports and studies on UZS. UZS has been reported following various ophthalmic interventions, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Penetrating keratoplasty for indications such as keratoconus, macular corneal dystrophy, granular corneal dystrophy, Fuchs endothelial corneal dystrophy, chemical injury, fungal corneal ulcer, leucoma, and herpetic keratitis.<xref ref-type="bibr" rid="article-166506.r5">[5]</xref><xref ref-type="bibr" rid="article-166506.r24">[24]</xref><xref ref-type="bibr" rid="article-166506.r25">[25]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>DALK for indications, including keratoconus, granular corneal dystrophy, and macular corneal dystrophy, may be associated with UZS.<xref ref-type="bibr" rid="article-166506.r26">[26]</xref><xref ref-type="bibr" rid="article-166506.r27">[27]</xref>&#x000a0;Specifically, DALK procedures involving Descemet membrane perforation and intracameral air usage may predispose to UZS.<xref ref-type="bibr" rid="article-166506.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Descemet stripping endothelial keratoplasty (DSEK) or DSAEK is performed for bullous keratopathy and corneal edema resulting from endothelial dysfunction.<xref ref-type="bibr" rid="article-166506.r27">[27]</xref><xref ref-type="bibr" rid="article-166506.r28">[28]</xref>&#x000a0;High&#x000a0;IOP and and a complex postoperative course, such as graft dislocation requiring rebubbling or re-DSAEK, may predispose to a dilated irregular pupil resembling Urrets-Zavalia syndrome.<xref ref-type="bibr" rid="article-166506.r28">[28]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Descemet membrane endothelial keratoplasty&#x000a0;(DMEK) is performed for Fuchs endothelial corneal dystrophy.<xref ref-type="bibr" rid="article-166506.r29">[29]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Intracameral gas (C3F8) injection is used for acute corneal hydrops.<xref ref-type="bibr" rid="article-166506.r30">[30]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cataract surgery (including small incision cataract surgery, phacoemulsification, and conventional extracapsular cataract extraction) with postoperative toxic anterior segment syndrome (TASS) has been associated with the development of Urrets-Zavalia syndrome.<xref ref-type="bibr" rid="article-166506.r31">[31]</xref><xref ref-type="bibr" rid="article-166506.r32">[32]</xref>&#x000a0;In a large study, the Ringer lactate solution was implicated in causing TASS, subsequently leading to Urrets-Zavalia syndrome.<xref ref-type="bibr" rid="article-166506.r32">[32]</xref>&#x000a0;Some authors suggest that toxic anterior segment syndrome and Urrets-Zavalia syndrome may represent a spectrum of the same entity.<xref ref-type="bibr" rid="article-166506.r31">[31]</xref>&#x000a0;Urrets-Zavalia syndrome has also been reported 3 weeks&#x000a0;after femtosecond laser-assisted cataract surgery, which was associated with anterior segment inflammation appearing 2 weeks post-surgery.<xref ref-type="bibr" rid="article-166506.r33">[33]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Scleral-fixated intraocular lens.<xref ref-type="bibr" rid="article-166506.r34">[34]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Trabeculectomy and combined trabeculotomy and trabeculectomy may be associated with Urrets-Zavalia syndrome.<xref ref-type="bibr" rid="article-166506.r11">[11]</xref><xref ref-type="bibr" rid="article-166506.r35">[35]</xref>&#x000a0;These patients may experience a complicated postoperative course, including hypotony requiring multiple surgeries and spikes in high IOP.<xref ref-type="bibr" rid="article-166506.r11">[11]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Goniotomy.<xref ref-type="bibr" rid="article-166506.r9">[9]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Minimally invasive glaucoma surgery.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Glaucoma drainage device.<xref ref-type="bibr" rid="article-166506.r36">[36]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Argon laser peripheral iridoplasty.<xref ref-type="bibr" rid="article-166506.r10">[10]</xref><xref ref-type="bibr" rid="article-166506.r11">[11]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Implantable collamer lens placement.<xref ref-type="bibr" rid="article-166506.r37">[37]</xref><xref ref-type="bibr" rid="article-166506.r38">[38]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Iatrogenic dilation of the pupil in patients with pigment dispersion syndrome.<xref ref-type="bibr" rid="article-166506.r39">[39]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Intravenous cidofovir injection with ocular hypotony.<xref ref-type="bibr" rid="article-166506.r40">[40]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-166506.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of Urrets-Zavalia syndrome&#x000a0;is rare and highly variable, with reported frequencies ranging from 0% to 17.7% after penetrating keratoplasty.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref><xref ref-type="bibr" rid="article-166506.r5">[5]</xref><xref ref-type="bibr" rid="article-166506.r41">[41]</xref><xref ref-type="bibr" rid="article-166506.r42">[42]</xref>&#x000a0;This variability may be due to differences in diagnostic criteria, underdiagnosis, and a transient, mild form in which the pupil size normalizes over time.<xref ref-type="bibr" rid="article-166506.r19">[19]</xref> The current literature does not provide an accurate overall incidence rate. Differences in frequency among sexes and age groups are not entirely known. Urrets-Zavalia syndrome typically occurs unilaterally despite bilateral surgery and affects males and females equally.<xref ref-type="bibr" rid="article-166506.r5">[5]</xref><xref ref-type="bibr" rid="article-166506.r35">[35]</xref><xref ref-type="bibr" rid="article-166506.r43">[43]</xref>&#x000a0;Bilateral cases of UZS have been reported in macular corneal dystrophy patients undergoing penetrating keratoplasty, possibly suggesting an abnormal iris or sphincter pupillae in both eyes.<xref ref-type="bibr" rid="article-166506.r24">[24]</xref></p>
      </sec>
      <sec id="article-166506.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of Urrets-Zavalia syndrome is not well understood but is likely multifactorial. Iris ischemia is considered a primary mechanism behind the pupillary sphincter dysfunction observed in UZS patients.<xref ref-type="bibr" rid="article-166506.r44">[44]</xref> The severity of ischemia and resulting atrophy determines the extent of dilation and the potential for the pupil to return to normal size.<xref ref-type="bibr" rid="article-166506.r3">[3]</xref><xref ref-type="bibr" rid="article-166506.r14">[14]</xref>&#x000a0;Additional possible mechanisms include intraoperative iatrogenic trauma to the iris, ciliary muscles, or ciliary ganglion, as well as toxic or idiosyncratic reactions to various agents, including anesthetics.<xref ref-type="bibr" rid="article-166506.r45">[45]</xref></p>
        <p>High intraoperative or postoperative IOP is thought to cause occlusion of the iris root vessels, leading to ischemia and subsequent iris atrophy.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref> In 1995, Tuft demonstrated through anterior-segment fluorescein angiography that keratoconus patients with high postoperative IOP after penetrating keratoplasty exhibited delayed filling of the iris vessels with late-stage leakage, indicative of iris ischemia.<xref ref-type="bibr" rid="article-166506.r44">[44]</xref>&#x000a0;Elevated IOP within the first 24 hours after surgery may be a strong predictive factor for the development of UZS.<xref ref-type="bibr" rid="article-166506.r19">[19]</xref> However, UZS cases have also been reported with normal IOP.<xref ref-type="bibr" rid="article-166506.r33">[33]</xref></p>
        <p>A proposed mechanism for why keratoconus patients may be at higher risk for Urrets-Zavalia syndrome after penetrating keratoplasty is that the low rigidity of keratoconic eyes may obstruct the peripheral iris vessels that insert into the sclera during the procedure.<xref ref-type="bibr" rid="article-166506.r44">[44]</xref> Another proposed theory is that patients with keratoconus may have intrinsic deficiencies in their irises and pupillary sphincter muscles, leading to a higher susceptibility to postoperative mydriasis.<xref ref-type="bibr" rid="article-166506.r41">[41]</xref>&#x000a0;Some authors have noted prompt and sustained pupillary dilation with mydriatic drop use in keratoconus patients, even if they do not undergo penetrating keratoplasty.<xref ref-type="bibr" rid="article-166506.r14">[14]</xref> Other hypotheses include a sudden increase in sympathetic effect on the pupil, a neurochemical defect of the sphincter pupillae or dilator pupillae, a lower amplitude of accommodation response suggesting abnormality of the iris and ciliary body, and iris hypoplasia.<xref ref-type="bibr" rid="article-166506.r4">[4]</xref>&#x000a0;However, However, a large study noted that atropine, high IOP, and keratoconus are not consistently seen in all cases of UZS.<xref ref-type="bibr" rid="article-166506.r24">[24]</xref>&#x000a0;Many authors have&#x000a0;suggested that keratoconus may not be a predisposing factor for UZS.<xref ref-type="bibr" rid="article-166506.r42">[42]</xref><xref ref-type="bibr" rid="article-166506.r46">[46]</xref></p>
        <p>Historically, mydriatic agents such as atropine were thought to have a role in the pathogenesis of UZS.<xref ref-type="bibr" rid="article-166506.r18">[18]</xref>&#x000a0;Atropine may cause permanent or prolonged mydriasis, or "abnormally great mydriasis," in Down syndrome due to hyperreactivity to atropine.<xref ref-type="bibr" rid="article-166506.r47">[47]</xref>&#x000a0;However, contradicting literature exists.<xref ref-type="bibr" rid="article-166506.r48">[48]</xref><xref ref-type="bibr" rid="article-166506.r49">[49]</xref>&#x000a0;Patients with pigment dispersion syndrome may also develop fixed dilated pupils after iatrogenic mydriasis.<xref ref-type="bibr" rid="article-166506.r39">[39]</xref> Drugs acting on both parasympathetic (including atropine and homatropine) and sympathetic (phenylephrine) pathways may be associated with UZS.<xref ref-type="bibr" rid="article-166506.r31">[31]</xref> The proposed mechanism is that the mydriasis induced by the instillation of these agents may increase contact between the iris and the cornea, causing iris atrophy and prolonged mydriasis.<xref ref-type="bibr" rid="article-166506.r50">[50]</xref>&#x000a0;Urrets-Zavalia syndrome may occur in the eyes without contact between the peripheral iris and the host cornea.<xref ref-type="bibr" rid="article-166506.r50">[50]</xref>&#x000a0;A study showed that postoperative mydriasis was detected equally in keratoconus patients who received or did not receive mydriatic agents during or after penetrating keratoplasty.<xref ref-type="bibr" rid="article-166506.r41">[41]</xref>&#x000a0;In addition, Urrets-Zavalia syndrome may occur in patients without a history of mydriatic use.<xref ref-type="bibr" rid="article-166506.r35">[35]</xref></p>
        <p>Ophthalmic viscosurgical devices or viscoelastic materials may be toxic to the pupillary sphincter or iris vasculature,&#x000a0;raising the notion that UZS may also be a sequelae of TASS.<xref ref-type="bibr" rid="article-166506.r31">[31]</xref> This hypothesis has been considered in cases of UZS following cataract surgery, where viscoelastic material was found in the anterior chamber angle.<xref ref-type="bibr" rid="article-166506.r20">[20]</xref> In addition, it has also been speculated that viscoelastic material retention may lead to an IOP spike and subsequent damage to the iris vasculature.<xref ref-type="bibr" rid="article-166506.r51">[51]</xref></p>
        <p>In addition to penetrating keratoplasty, other ophthalmic surgeries have been associated with the development of Urrets-Zavalia syndrome, and their potential mechanisms have been described. Air bubble formation in the anterior chamber with subsequent posterior displacement of the iris is thought to be the reason for Urrets-Zavalia syndrome after DALK and DSAEK.<xref ref-type="bibr" rid="article-166506.r22">[22]</xref><xref ref-type="bibr" rid="article-166506.r52">[52]</xref>&#x000a0;Various glaucoma surgeries such as argon laser peripheral iridoplasty (ALPI), trabeculectomy (TREC), and goniotomy may lead to permanent mydriasis, possibly due to injury of the parasympathetic radial nerve fibers to the pupillary sphincter muscle.<xref ref-type="bibr" rid="article-166506.r9">[9]</xref><xref ref-type="bibr" rid="article-166506.r10">[10]</xref><xref ref-type="bibr" rid="article-166506.r11">[11]</xref></p>
      </sec>
      <sec id="article-166506.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A biopsy from a keratoconus patient who developed Urrets-Zavalia syndrome after penetrating keratoplasty showed stromal fibrosis and dilated iris vessels (vascular congestion).<xref ref-type="bibr" rid="article-166506.r53">[53]</xref>&#x000a0;The Schlemm canal was patent, and the trabecular meshwork appeared normal in the specimen taken after a trabeculectomy. Lymphoid cells were present around the Schlemm canal. The posterior pigmentary epithelium was normal, and no neovascularization with thin walls was observed in this report.<xref ref-type="bibr" rid="article-166506.r53">[53]</xref></p>
      </sec>
      <sec id="article-166506.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with Urrets-Zavalia syndrome typically present with an atonic pupil that does not react to light, accommodation, or pilocarpine and may experience glare, halos, and photophobia.<xref ref-type="bibr" rid="article-166506.r3">[3]</xref> The onset is usually within the first 1 to 2 weeks after penetrating keratoplasty.<xref ref-type="bibr" rid="article-166506.r24">[24]</xref> However, Urrets-Zavalia syndrome has been reported up to 5 months postoperatively.<xref ref-type="bibr" rid="article-166506.r19">[19]</xref>&#x000a0;IOP may be elevated, and there may be evidence of glaucomatous optic nerve head damage.<xref ref-type="bibr" rid="article-166506.r54">[54]</xref></p>
        <p>On slit lamp examination, diffuse atrophy of the anterior and posterior layers of the iris with posterior synechiae and glaukomflecken may be observed in the complete form of Urrets-Zavalia syndrome.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref><xref ref-type="bibr" rid="article-166506.r55">[55]</xref>&#x000a0;The permanent mydriasis observed in the complete form of Urrets-Zavalia syndrome caused by diffuse iris atrophy may lead to adhesions and occlusions of the anterior chamber angle, resulting in secondary acute angle-closure glaucoma.<xref ref-type="bibr" rid="article-166506.r56">[56]</xref></p>
        <p>The incomplete and transient forms of Urrets-Zavalia syndrome may exhibit anterior layer atrophy of the iris with pigmentary granules on the corneal endothelium and anterior lens capsule.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref>&#x000a0;Sequelae of TASS, including corneal decompensation, posterior synechia, pigment deposition on the anterior surface of the lens, and corneal endothelium, may also be observed. Features suggestive of iris ischemia or strangulation, including transillumination defects, may be present. In the complete form of Urrets-Zavalia syndrome, the pupil fails to constrict even after topical instillation of pilocarpine 2% or 4% eye drops.<xref ref-type="bibr" rid="article-166506.r45">[45]</xref></p>
      </sec>
      <sec id="article-166506.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A thorough medical and surgical history should be obtained from the patient, including a review of medications to identify any use of mydriatic agents. Visual acuity, postoperative IOP, and pupillary examination should be adequately performed.</p>
        <p>A feared complication of Urrets-Zavalia syndrome, as mentioned before, is secondary acute-angle closure glaucoma.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref>&#x000a0;After evaluation and diagnosis of Urrets-Zavalia syndrome&#x000a0;via slit lamp examination, a gonioscopy should be performed to assess the presence and degree of adhesions or peripheral anterior synechiae in the anterior chamber angle.<xref ref-type="bibr" rid="article-166506.r56">[56]</xref> Ultrasound biomicroscopy (UBM) can be considered in cases of unsuccessful gonioscopy. Ancillary testing such as corneal tomography, optical coherence tomography (corneal thickness, anterior segment or angle of the anterior chamber, posterior segment, and optic nerve), and anterior segment fluorescein angiography can be considered but not required for diagnosis.</p>
        <p>Anterior segment indocyanine green angiogram shows delayed and reduced filling of the iris vessels compared to control, suggesting iris ischemia's crucial role in the causation of Urrets-Zavalia syndrome.<xref ref-type="bibr" rid="article-166506.r19">[19]</xref></p>
      </sec>
      <sec id="article-166506.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Currently, no definitive treatment has been provided for Urrets-Zavalia syndrome&#x000a0;at this time. Current literature regarding medical therapy has suggested the use of dapiprazole <xref ref-type="bibr" rid="article-166506.r57">[57]</xref> and guanethidine drops <xref ref-type="bibr" rid="article-166506.r13">[13]</xref> due to their sympatholytic mechanisms and ability to induce miosis. A study demonstrated successful treatment of iris sympathetic spasms and miosis with guanethidine 5% eye drops every 4 hours for 24 hours, followed by pilocarpine 2% drops the next day.<xref ref-type="bibr" rid="article-166506.r58">[58]</xref> However, further research is needed to evaluate the safety and effectiveness of these medications. Control of intraocular inflammation and management of IOP remain crucial aspects of treatment.&#x000a0;</p>
        <p>Surgical interventions are reserved for cases where there is iridocorneal contact and a shallow anterior chamber. A cyclodialysis spatula can be used to disrupt adhesions in the anterior chamber angle and restore the anterior chamber.<xref ref-type="bibr" rid="article-166506.r50">[50]</xref>&#x000a0;Pupilloplasty may be necessary for patients experiencing severe photophobia that cannot be managed with sunglasses and other conservative measures. Various techniques of pupilloplasty have been reported, including single-pass and 4-throw pupilloplasty.<xref ref-type="bibr" rid="article-166506.r59">[59]</xref>&#x000a0;Additional options for controlling photophobia due to dilated pupils include corneal tattoos, femtosecond-assisted keratopigmentation, contact lenses, and diaphragm intraocular lenses.<xref ref-type="bibr" rid="article-166506.r60">[60]</xref>&#x000a0;In cases where IOP needs to be controlled, glaucoma surgery may be required. Some cases may also necessitate anterior segment reconstruction.</p>
        <p>Several preventative measures have been utilized preoperatively thus far based on current theories regarding risk factors. Preoperative administration of intravenous mannitol 20% has been used to reduce vitreous humor volume and mitigate iris strangulation caused by intraoperative spikes in IOP.<xref ref-type="bibr" rid="article-166506.r16">[16]</xref> YAG laser iridotomy may also be performed a day before penetrating keratoplasty to manage elevated IOP.<xref ref-type="bibr" rid="article-166506.r17">[17]</xref>&#x000a0;Intraoperatively, the surgeon must exercise caution to prevent surgical trauma to the iris and ensure adequate anterior chamber depth. If viscoelastic material is used, it should be thoroughly removed from the anterior chamber to prevent potential toxic reactions. Some surgeons advocate for peripheral surgical iridectomy during penetrating keratoplasty to prevent pupillary block and iris strangulation,<xref ref-type="bibr" rid="article-166506.r61">[61]</xref>&#x000a0;although the efficacy of iridectomy in preventing Urrets-Zavalia syndrome is debated among authors.<xref ref-type="bibr" rid="article-166506.r4">[4]</xref>&#x000a0;</p>
        <p>Urrets-Zavalia syndrome may be associated with intracameral air or gas, particularly in procedures such as DSAEK and DALK with Descemet membrane perforation, highlighting the need for cautious use of these agents and consideration of intravenous mannitol.<xref ref-type="bibr" rid="article-166506.r23">[23]</xref>&#x000a0;The&#x000a0;role of preoperative antiglaucoma medications in preventing UZS remains uncertain. Controversy surrounds the use of postoperative mydriatics, which some authors speculate may contribute to the onset of Urrets-Zavalia syndrome. Recommendations include avoiding potent mydriatics such as atropine or homatropine and considering the use of short-acting agents such as phenylephrine on alternate days.<xref ref-type="bibr" rid="article-166506.r4">[4]</xref></p>
      </sec>
      <sec id="article-166506.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A thorough differential diagnosis should be undertaken upon observing a patient with a dilated and fixed pupil following ophthalmic surgery. The following conditions should be considered when encountering a patient with a unilaterally atonic pupil:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute angle-closure glaucoma</p>
          </list-item>
          <list-item>
            <p>Anterior uveitis</p>
          </list-item>
          <list-item>
            <p>Posterior synechiae</p>
          </list-item>
          <list-item>
            <p>Pupillary block</p>
          </list-item>
          <list-item>
            <p>Neurogenic syphilis</p>
          </list-item>
          <list-item>
            <p>Iatrogenic iris trauma</p>
          </list-item>
          <list-item>
            <p>Traumatic mydriasis</p>
          </list-item>
          <list-item>
            <p>Adie pupil</p>
          </list-item>
          <list-item>
            <p>Pharmacologic mydriasis</p>
          </list-item>
          <list-item>
            <p>Third nerve palsy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-166506.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Approximately 30% to 70% of patients with Urrets-Zavalia syndrome&#x000a0;will regain some form of pupil reactivity within 18 weeks after onset.<xref ref-type="bibr" rid="article-166506.r62">[62]</xref>&#x000a0;Jastaneiah et al reported that only 4.8% of UZS patients regain a normal pupil size, focusing on the complete form of Urrets-Zavalia syndrome.<xref ref-type="bibr" rid="article-166506.r24">[24]</xref>&#x000a0;Potential predictors for recovery of pupillary light reflex and normal pupillary size include prompt control of postoperative IOP rise, light reaction in the dilated pupil, and pupillary constriction with topical pilocarpine 2% eye drops.<xref ref-type="bibr" rid="article-166506.r37">[37]</xref>&#x000a0;Around 30% of cases never recover pupillary movement.<xref ref-type="bibr" rid="article-166506.r45">[45]</xref>&#x000a0;Permanently fixed dilated pupils may require pupilloplasty or other interventions if the patient experiences photophobia.</p>
      </sec>
      <sec id="article-166506.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The major complication of Urrets-Zavalia syndrome&#x000a0;is secondary acute angle-closure glaucoma, which occurs due to the formation of iridocorneal adhesions and subsequent collapse of the anterior chamber angle.<xref ref-type="bibr" rid="article-166506.r1">[1]</xref> Prompt diagnosis is essential to preserve the patient&#x02019;s optic nerve and vision. Management includes the use of IOP-lowering medications and subsequent surgical interventions aimed at adhesion removal and reformation of the anterior chamber.<xref ref-type="bibr" rid="article-166506.r50">[50]</xref></p>
      </sec>
      <sec id="article-166506.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with Urrets-Zavalia syndrome should be counseled by their healthcare providers about the risks of developing acute angle-closure glaucoma. They should avoid dimly lit environments to prevent further mydriasis and narrowing of the iridocorneal angle. Additionally, patients should be cautioned against using medications such as specific anticholinergic, adrenergic, antidepressant, and sulfa-based agents, which can exacerbate mydriasis and increase the risk of angle-closure glaucoma.<xref ref-type="bibr" rid="article-166506.r63">[63]</xref>&#x000a0;</p>
        <p>Patients with Urrets-Zavalia syndrome who have hypermetropia should also receive education about their inherent risk for angle-closure glaucoma. These individuals have an anatomical predisposition to a shallow anterior chamber depth or a more anteriorly located lens, both of which can increase the likelihood of angle-closure glaucoma.<xref ref-type="bibr" rid="article-166506.r64">[64]</xref></p>
      </sec>
      <sec id="article-166506.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Clinicians should consider Urrets-Zavalia syndrome&#x000a0;as a possible complication following penetrating keratoplasty or other ophthalmic surgeries. General practitioners, nurses, and other multidisciplinary healthcare team members should include this diagnosis in their differential for an atonic pupil after eye surgery. They should promptly refer the patient to their optometrist or ophthalmologist. Careful pre- and intraoperative measures should be planned and adopted to minimize the&#x000a0;risk of Urrets-Zavalia syndrome. Although rare, Urrets-Zavalia syndrome should not be overlooked in the early postoperative period due to the potential for secondary acute angle-closure glaucoma, which can threaten vision. The implementation of the preventive measures discussed above may reduce the risk and incidence of Urrets-Zavalia syndrome.</p>
      </sec>
      <sec id="article-166506.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=166506&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=166506">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/urrets-zavalia-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=166506">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/166506/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=166506">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-166506.s15">
        <title>References</title>
        <ref id="article-166506.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>URRETS ZAVALIA</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>FIXED, DILATED PUPIL, IRIS ATROPHY AND SECONDARY GLAUCOMA.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1963</year>
            <month>Aug</month>
            <volume>56</volume>
            <fpage>257</fpage>
            <page-range>257-65</page-range>
            <pub-id pub-id-type="pmid">14061605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magalh&#x000e3;es</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Kronbauer</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Sanvicente</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>Update and review of Urrets-Zavalia syndrome.</article-title>
            <source>Arq Bras Oftalmol</source>
            <year>2016</year>
            <season>May-Jun</season>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-4</page-range>
            <pub-id pub-id-type="pmid">27463637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gasset</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupil following penetrating keratoplasty in keratoconus (Castroviejo syndrome).</article-title>
            <source>Ann Ophthalmol</source>
            <year>1977</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>623</fpage>
            <page-range>623-6</page-range>
            <pub-id pub-id-type="pmid">143227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spierer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome (fixed and dilated pupil following penetrating keratoplasty for keratoconus) and its variants.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2014</year>
            <season>May-Jun</season>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>304</fpage>
            <page-range>304-10</page-range>
            <pub-id pub-id-type="pmid">24560126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors of Urrets-Zavalia Syndrome after Penetrating Keratoplasty.</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>Feb</month>
            <day>22</day>
            <volume>11</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">35268266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jovanovi&#x00107;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nikoli&#x00107;</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome after deep anterior lamellar keratoplasty.</article-title>
            <source>Vojnosanit Pregl</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>73</volume>
            <issue>10</issue>
            <fpage>973</fpage>
            <page-range>973-5</page-range>
            <pub-id pub-id-type="pmid">29328565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarezky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Orlin</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Bilateral Urrets-Zavalia Syndrome After Descemet Stripping Automated Endothelial Keratoplasty.</article-title>
            <source>Cornea</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-115</page-range>
            <pub-id pub-id-type="pmid">27490053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Golnik</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Hund</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Apple</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Atonic pupil after cataract surgery.</article-title>
            <source>J Cataract Refract Surg</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>170</fpage>
            <page-range>170-5</page-range>
            <pub-id pub-id-type="pmid">7791057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chelnis</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Sieminski</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome following goniotomy in a child.</article-title>
            <source>J AAPOS</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>312</fpage>
            <page-range>312-3</page-range>
            <pub-id pub-id-type="pmid">22681954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Espana</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Ioannidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tello</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liebmann</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ritch</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome as a complication of argon laser peripheral iridoplasty.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-9</page-range>
            <pub-id pub-id-type="pmid">16987896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klezlova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liebezeit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prokosch-Willing</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gericke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia Syndrome After Combined Trabeculotomy-Trabeculectomy Surgery.</article-title>
            <source>J Glaucoma</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>e80</fpage>
            <page-range>e80-e83</page-range>
            <pub-id pub-id-type="pmid">29394202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaeser</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Kawasaki</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Disorders of pupillary structure and function.</article-title>
            <source>Neurol Clin</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>657</fpage>
            <page-range>657-77</page-range>
            <pub-id pub-id-type="pmid">20637995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonnet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lemarchands</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Prevention and treatment of the "irreducible mydriasis--progressive atrophy of the iris" syndrome following perforating keratoplasty for keratoconus].</article-title>
            <source>Ann Ocul (Paris)</source>
            <year>1969</year>
            <month>Nov</month>
            <volume>202</volume>
            <issue>11</issue>
            <fpage>1139</fpage>
            <page-range>1139-46</page-range>
            <pub-id pub-id-type="pmid">5403350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davies</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Ruben</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The paretic pupil: its incidence and aetiology after keratoplasty for keratoconus.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1975</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>223</fpage>
            <page-range>223-8</page-range>
            <pub-id pub-id-type="pmid">1095050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walton</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome following goniotomy in a child.</article-title>
            <source>J AAPOS</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>114</fpage>
            <page-range>114-5</page-range>
            <pub-id pub-id-type="pmid">23273938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharif</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Penetrating keratoplasty for keratoconus: complications and long-term success.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>75</volume>
            <issue>3</issue>
            <fpage>142</fpage>
            <page-range>142-6</page-range>
            <pub-id pub-id-type="pmid">1826453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tourtas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Laaser</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Cursiefen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>153</volume>
            <issue>6</issue>
            <fpage>1082</fpage>
            <page-range>1082-90.e2</page-range>
            <pub-id pub-id-type="pmid">22397955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alberth</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schnitzler</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Irreversible mydriasis following keratoplasty for keratokonus].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>1971</year>
            <month>Sep</month>
            <volume>159</volume>
            <issue>3</issue>
            <fpage>330</fpage>
            <page-range>330-5</page-range>
            <pub-id pub-id-type="pmid">4946105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Figueiredo</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Kolli</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gales</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome following penetrating keratoplasty for keratoconus.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>251</volume>
            <issue>3</issue>
            <fpage>809</fpage>
            <page-range>809-15</page-range>
            <pub-id pub-id-type="pmid">22965868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Humphry</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>The fixed dilated pupil after cataract surgery--is it related to intraocular use of hypromellose?</article-title>
            <source>Br J Ophthalmol</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>77</volume>
            <issue>10</issue>
            <fpage>639</fpage>
            <page-range>639-41</page-range>
            <pub-id pub-id-type="pmid">8218032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maurino</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Allan</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Tuft</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupil (Urrets-Zavalia syndrome) after air/gas injection after deep lamellar keratoplasty for keratoconus.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>133</volume>
            <issue>2</issue>
            <fpage>266</fpage>
            <page-range>266-8</page-range>
            <pub-id pub-id-type="pmid">11812433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minasian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ayliffe</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupil following deep lamellar keratoplasty (Urrets-Zavalia syndrome).</article-title>
            <source>Br J Ophthalmol</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>86</volume>
            <issue>1</issue>
            <fpage>115</fpage>
            <page-range>115-6</page-range>
            <pub-id pub-id-type="pmid">11801517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bozkurt</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Acar</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Acar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupilla as a common complication of deep anterior lamellar keratoplasty complicated with Descemet membrane perforation.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2013</year>
            <season>Mar-Apr</season>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-70</page-range>
            <pub-id pub-id-type="pmid">23065856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jastaneiah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Towerki</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Al-Assiri</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupil after penetrating keratoplasty for macular corneal dystrophy and keratoconus.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>140</volume>
            <issue>3</issue>
            <fpage>484</fpage>
            <page-range>484-9</page-range>
            <pub-id pub-id-type="pmid">16084784</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Srinivasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patnaik</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupil (Urrets-Zavalia syndrome) in corneal dystrophies.</article-title>
            <source>Cornea</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-3</page-range>
            <pub-id pub-id-type="pmid">14701963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niknam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rajabi</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupil (urrets-zavalia syndrome) after deep anterior lamellar keratoplasty.</article-title>
            <source>Cornea</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>1187</fpage>
            <page-range>1187-90</page-range>
            <pub-id pub-id-type="pmid">19770716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foroutan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tabatabaei</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Soleimani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nekoozadeh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome in different methods of keratoplasty.</article-title>
            <source>Int J Ophthalmol</source>
            <year>2016</year>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>1358</fpage>
            <page-range>1358-60</page-range>
            <pub-id pub-id-type="pmid">27672606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anwar</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Prasher</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bowman</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Mootha</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>Features of Urrets-Zavalia syndrome after descemet stripping automated endothelial keratoplasty.</article-title>
            <source>Cornea</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>1330</fpage>
            <page-range>1330-4</page-range>
            <pub-id pub-id-type="pmid">22960674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holtmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Spaniol</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Geerling</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome after Descemet membrane endothelial keratoplasty.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2015</year>
            <month>Jul</month>
            <day>30</day>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>e75</fpage>
            <page-range>e75-7</page-range>
            <pub-id pub-id-type="pmid">25768696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aralikatti</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Tomlins</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome following intracameral C3F8 injection for acute corneal hydrops.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>198</fpage>
            <page-range>198-9</page-range>
            <pub-id pub-id-type="pmid">18352891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ganesan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kaliaperumal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Toxic anterior segment syndrome and Urrets-Zavalia syndrome: Spectrum of the same entity?</article-title>
            <source>Oman J Ophthalmol</source>
            <year>2023</year>
            <season>Jan-Apr</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-44</page-range>
            <pub-id pub-id-type="pmid">37007266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nizamani</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Bhutto</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Talpur</surname>
                <given-names>KI</given-names>
              </name>
            </person-group>
            <article-title>Cluster of Urrets-Zavalia syndrome: a sequel of toxic anterior segment syndrome.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>8</issue>
            <fpage>976</fpage>
            <page-range>976-9</page-range>
            <pub-id pub-id-type="pmid">23410729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurtz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fradkin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia Syndrome Following Cataract Surgery.</article-title>
            <source>Case Rep Ophthalmol</source>
            <year>2021</year>
            <season>May-Aug</season>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>659</fpage>
            <page-range>659-663</page-range>
            <pub-id pub-id-type="pmid">34413758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sylla</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Gelnick</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leskov</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome following placement of scleral-sutured intraocular lens.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>34</volume>
            <fpage>102010</fpage>
            <pub-id pub-id-type="pmid">38384736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Assi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murdoch</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome following trabeculectomy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>84</volume>
            <issue>3</issue>
            <fpage>338</fpage>
            <page-range>338-9</page-range>
            <pub-id pub-id-type="pmid">10744383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gharbiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Colica</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Campagna</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>De Vico</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Cruciani</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Urrets- Zavalia Syndrome after glaucoma filtration device implantation.</article-title>
            <source>Clin Ter</source>
            <year>2013</year>
            <volume>164</volume>
            <issue>5</issue>
            <fpage>e381</fpage>
            <page-range>e381-2</page-range>
            <pub-id pub-id-type="pmid">24217839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niruthisard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kasetsuwan</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Unilateral Urrets-Zavalia syndrome after Implantable Collamer Lens implantation: a case report and review of the literature.</article-title>
            <source>J Med Case Rep</source>
            <year>2021</year>
            <month>Sep</month>
            <day>22</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>467</fpage>
            <pub-id pub-id-type="pmid">34548112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Habash</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Arfaj</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Al Abdulsalam</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome after implantable Collamer lens placement.</article-title>
            <source>Digit J Ophthalmol</source>
            <year>2015</year>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">27330468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mocan</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Irkec</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Orhan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome following iatrogenic pupil dilation in eyes with pigment dispersion.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>216</fpage>
            <page-range>216-7</page-range>
            <pub-id pub-id-type="pmid">19491966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orssaud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wermert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laccourreye</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sors</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Roche</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dufier</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Urrets-Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment.</article-title>
            <source>Eye (Lond)</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>776</fpage>
            <page-range>776-7</page-range>
            <pub-id pub-id-type="pmid">24675584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertelsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Seim</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Irreversible mydriasis following keratoplasty in keratoconus [proceedings].</article-title>
            <source>Acta Ophthalmol Suppl</source>
            <year>1975</year>
            <issue>125</issue>
            <fpage>45</fpage>
            <page-range>45-6</page-range>
            <pub-id pub-id-type="pmid">184671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naumann</surname>
                <given-names>GO</given-names>
              </name>
            </person-group>
            <article-title>Iris ischaemia following penetrating keratoplasty for keratoconus (Urrets-Zavalia syndrome).</article-title>
            <source>Cornea</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>120</fpage>
            <pub-id pub-id-type="pmid">8985644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhullar</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Venkateswaran</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Case Series of Urrets-Zavalia Syndrome After Descemet Membrane Endothelial Keratoplasty.</article-title>
            <source>Cornea</source>
            <year>2021</year>
            <month>May</month>
            <day>01</day>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>652</fpage>
            <page-range>652-655</page-range>
            <pub-id pub-id-type="pmid">33065714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuft</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Buckley</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Iris ischaemia following penetrating keratoplasty for keratoconus (Urrets-Zavalia syndrome).</article-title>
            <source>Cornea</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>618</fpage>
            <page-range>618-22</page-range>
            <pub-id pub-id-type="pmid">8575186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawasaki</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic approach to pupillary abnormalities.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>4 Neuro-ophthalmology</issue>
            <fpage>1008</fpage>
            <page-range>1008-22</page-range>
            <pub-id pub-id-type="pmid">25099106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geyer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rothkoff</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lazar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Atropine in keratoplasty for keratoconus.</article-title>
            <source>Cornea</source>
            <year>1991</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>372</fpage>
            <page-range>372-3</page-range>
            <pub-id pub-id-type="pmid">1935132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Goodman</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Hyper-reactivity to atropine in Down's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1968</year>
            <month>Aug</month>
            <day>22</day>
            <volume>279</volume>
            <issue>8</issue>
            <fpage>407</fpage>
            <page-range>407-10</page-range>
            <pub-id pub-id-type="pmid">4232839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parsa</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Adyanthaya</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Why atropine drops should be used in Down syndrome.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>295</fpage>
            <page-range>295-6</page-range>
            <pub-id pub-id-type="pmid">18227213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mir</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Cumming</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Response to atropine in Down's syndrome.</article-title>
            <source>Arch Dis Child</source>
            <year>1971</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>245</issue>
            <fpage>61</fpage>
            <page-range>61-5</page-range>
            <pub-id pub-id-type="pmid">4252208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Urrets-Zavalia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management of keratoplasty in the early stages.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1977</year>
            <month>Feb</month>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-91</page-range>
            <pub-id pub-id-type="pmid">321004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Causes and management strategies for elevated intraocular pressure after implantable collamer lens implantation.</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2024</year>
            <volume>11</volume>
            <fpage>1351272</fpage>
            <pub-id pub-id-type="pmid">38384405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fourni&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ponchel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Malecaze</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Arn&#x000e9;</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Fixed dilated pupil (urrets-zavalia syndrome) and anterior subcapsular cataract formation after descemet stripping endothelial keratoplasty.</article-title>
            <source>Cornea</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>1184</fpage>
            <page-range>1184-6</page-range>
            <pub-id pub-id-type="pmid">19730095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Suarez-Pe&#x000f1;aranda</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Diez-Feijoo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pazos</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sanchez-Salorio</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Histopathological and ultrasound biomicroscopy findings in a case of irreversible mydriasis after keratoplasty in keratoconus.</article-title>
            <source>Acta Ophthalmol Scand</source>
            <year>1997</year>
            <month>Aug</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>474</fpage>
            <page-range>474-6</page-range>
            <pub-id pub-id-type="pmid">9374265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r54">
          <label>54</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mahabadi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zeppieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Open Angle Glaucoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">28722917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soldevila</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rojas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferragut-Alegre</surname>
                <given-names>&#x000c1;</given-names>
              </name>
            </person-group>
            <article-title>Regression of Glaukomflecken in Urrets-Zaval&#x000ed;a syndrome after myopic ICL implantation.</article-title>
            <source>J Fr Ophtalmol</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>104089</fpage>
            <pub-id pub-id-type="pmid">38382276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grzybowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Urrets-Zaval&#x000ed;a</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ascaso</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Alberto Urrets-Zaval&#x000ed;a Jr, MD, PhD (1920-2010).</article-title>
            <source>Am J Ophthalmol</source>
            <year>2013</year>
            <month>May</month>
            <volume>155</volume>
            <issue>5</issue>
            <fpage>957</fpage>
            <page-range>957-8</page-range>
            <pub-id pub-id-type="pmid">23717831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spadea</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Regression of urrets-zavalia syndrome after deep lamellar keratoplasty for keratoconus: a case study.</article-title>
            <source>Open Ophthalmol J</source>
            <year>2008</year>
            <month>Aug</month>
            <day>08</day>
            <volume>2</volume>
            <fpage>130</fpage>
            <page-range>130-1</page-range>
            <pub-id pub-id-type="pmid">19516912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lagoutte</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thienpont</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Comte</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Proposed treatment of the Urrets-Zavalia syndrome. A propos of one reversible case].</article-title>
            <source>J Fr Ophtalmol</source>
            <year>1983</year>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>291</fpage>
            <page-range>291-4</page-range>
            <pub-id pub-id-type="pmid">6348146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ashok Kumar</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Single-pass four-throw pupilloplasty for Urrets-Zavalia syndrome.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>552</fpage>
            <page-range>552-558</page-range>
            <pub-id pub-id-type="pmid">30058383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alio</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Toffaha</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>El Aswad</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Femtosecond-assisted keratopigmentation double tunnel technique in the management of a case of Urrets-Zavalia syndrome.</article-title>
            <source>Cornea</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>9</issue>
            <fpage>1071</fpage>
            <page-range>1071-4</page-range>
            <pub-id pub-id-type="pmid">22531435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>NX</given-names>
              </name>
              <name>
                <surname>Langenbucher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>K&#x000fc;chle</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Frequency and risk factors of intraocular pressure increase after penetrating keratoplasty].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>217</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-81</page-range>
            <pub-id pub-id-type="pmid">11022660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Isac</surname>
                <given-names>MMS</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>DSJ</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous Pupillary Recovery of Urrets-Zavalia Syndrome Following Descemet's Membrane Endothelial Keratoplasty.</article-title>
            <source>Med Hypothesis Discov Innov Ophthalmol</source>
            <year>2019</year>
            <season>Spring</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-10</page-range>
            <pub-id pub-id-type="pmid">30923716</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced Acute Angle-closure Glaucoma: A Review.</article-title>
            <source>J Curr Glaucoma Pract</source>
            <year>2019</year>
            <season>Sep-Dec</season>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>104</fpage>
            <page-range>104-109</page-range>
            <pub-id pub-id-type="pmid">32435123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-166506.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pardeshi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Burkemper</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Apolo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McKean-Cowdin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Varma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>BY</given-names>
              </name>
            </person-group>
            <article-title>Refractive Error and Anterior Chamber Depth as Risk Factors in Primary Angle Closure Disease: The Chinese American Eye Study.</article-title>
            <source>J Glaucoma</source>
            <year>2023</year>
            <month>Apr</month>
            <day>01</day>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>257</fpage>
            <page-range>257-264</page-range>
            <pub-id pub-id-type="pmid">36847699</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
